Search Results - "Saim Kerman"

Türkiye'de Meme Kanseri Tedavisinde Ruhsatsız ve Endikasyon Dışı İlaç Kullanım Sıklığı: Yasama ve Düzenleme Politikasının Değerlendirilmesi by Tanyeri, Pelin, Kockaya, Guvenc, Buyukokuroglu, Mehmet Emin, Durmus, Nedim, Vural, İsmail Mert, Akbulat, Akif, Kerman, Saim

“…Bu çalışmanın amacı, Türkiye’de meme kanseri tedavisinde ruhsatsız ve endikasyon dışı ilaç kullanımını değerlendirmektir. Bu çalışmaya trastuzumab veya diğer…”
Get full text

Results of reference pricing and reimbursement discount rate schemes of Turkey by Guvenc Kockaya, Kagan Atikeler, Esin Tuna, Pelin Kılıc, Pelin Tanyeri, Nurcan Umman, İsmail Mert Vural, Omer Altun, Akif Akbulat, Guven Artiran, Ercan Simsek, Hakkı Gursoz, Saim Kerman

“…OBJECTIVES: General Directorate of Pharmaceuticals and Pharmacy (IEGM) is responsible for setting all prices for human medicinal products. The reference…”
Get full text

Treatment cost of metastatic colon cancer in Turkey by Guvenc Kockaya, Mine Polat, Albert Wertheimer, Ahmet Ozet, Simten Malhan, İsmail Mert Vural, Akif Akbulat, Guven Artıran, Hakkı Gursoz, Saim Kerman

“…OBJECTIVES: Colon cancer is the third most common in the top cancer incidence list in Europe. In Europe 212,000 patients die every year due to colon cancer. In…”
Get full text

ADHD Medication Trends in Turkey: 2009-2013 by Öner, Özgür, Yilmaz, Esra Şafak, Karadağ, Hasan, Vural, Mert, Vural, Elif Hilal, Akbulat, Akif, Gürsöz, Hakkı, Türkçapar, Hakan, Kerman, Saim

“…Objective: To investigate the change of ADHD medication prescriptions in Turkey between 2009 and 2013. Method: Consumption data of ADHD medications, immediate…”
Get full text

Impact of Health Policy Changes on Trends in the Pharmaceutical Market in Turkey by Yılmaz, Esra Safak, Koçkaya, Güvenç, Yenilmez, Fatma Betül, Saylan, Mete, Tatar, Mehtap, Akbulat, Akif, Gürsöz, Hakkı, Kerman, Saim

“…The implementation phase of the Turkish Health Transformation Program (HTP) began in 2003, with the aim of organizing, financing, and delivering health care…”
Get full text

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future by de Bruijn, Winnie, Ibáñez, Cristina, Frisk, Pia, Bak Pedersen, Hanne, Alkan, Ali, Vella Bonanno, Patricia, Brkičić, Ljiljana S, Bucsics, Anna, Dedet, Guillaume, Eriksen, Jaran, Fadare, Joseph O, Fürst, Jurij, Gallego, Gisselle, Godói, Isabella P, Guerra Júnior, Augusto A, Gürsöz, Hakkı, Jan, Saira, Jones, Jan, Joppi, Roberta, Kerman, Saim, Laius, Ott, Madzikwa, Newman, Magnússon, Einar, Maticic, Mojca, Markovic-Pekovic, Vanda, Massele, Amos, Ogunleye, Olayinka, O'Leary, Aisling, Piessnegger, Jutta, Sermet, Catherine, Simoens, Steven, Tiroyakgosi, Celda, Truter, Ilse, Thyberg, Magnus, Tomekova, Kristina, Wladysiuk, Magdalena, Vandoros, Sotiris, Vural, Elif H, Zara, Corinne, Godman, Brian

“…Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a diagnosed prevalence of 2.0%. Fortunately, it is now curable in most…”
Get full text

Opioids for cancer pain: availability, accessibility, and regulatory barriers in Turkey and Pallia-Turk Project by Ozgul, Nejat, Koc, Orhan, Gultekin, Murat, Goksel, Fatih, Kerman, Saim, Tanyeri, Pelin, Ekinci, Halil, Tuncer, Murat A, Sencan, Irfan

“…Palliative care is an emerging topic in Turkey within recent years. Currently, there are only few number of palliative care services across the country and…”
Get full text

An Overview of the Orphan Medicines Market in Turkey by Koçkaya, Güvenç, Wertheimer, Albert I., Kilic, Pelin, Tanyeri, Pelin, Mert Vural, İ., Akbulat, Akif, Artiran, Guven, Kerman, Saim

“…The health policies of many countries and regions have already defined orphan drugs for rare diseases. Although there is no official definition of orphan drugs…”
Get full text

Orphan drug regulations in Turkey by Kılıç, Pelin, Koçkaya, Güvenç, Yemşen, Ömer, Tan, Celil, Öztunca, Fikriye Handan, Aksungur, Pelin, Kerman, Saim

Get full text

Orphan drug regulations in Turkey: Orphan drugs in Turkey by Kılıç, Pelin, Koçkaya, Güvenç, Yemşen, Ömer, Tan, Celil, Öztunca, Fikriye Handan, Aksungur, Pelin, Kerman, Saim

Get full text

Compassionate medicine-use programmes in Turkey: a report on current status by Vural, Elif H., Kockaya, Guvenc, Tanyeri, Pelin, Babacan, Salih, Vural, İ. Mert, Akbulat, Akif, Artıran, Güven, Akar, Halil, Tokaç, Mahmut, Kerman, Saim

“…Objective  In Turkey, compassionate use (CU) programmes were started in 2006. Patients suffering from a serious or urgent life‐threatening disease, who have…”
Get full text

Off-label and unlicensed oncology medicine use in Turkey: a retrospective analysis of computer records of the Turkish Ministry of Health by Koçkaya, Güvenç, Polat, Mine, Vural, İsmail Mert, Akbulat, Akif, Dedeoglu, Burcak Deniz, Akar, Halil, Kerman, Saim

“…Objectives  The use of off‐label medications is very common. A study published in 2006 found that off‐label use was most common for cardiac medications and…”
Get full text

Off-label and unlicensed oncology medicine use in Turkey: a retrospective analysis of computer records of the Turkish Ministry of Health: Unlicensed oncology medicine use in Turkey by Koçkaya, Güvenç, Polat, Mine, Vural, İsmail Mert, Akbulat, Akif, Dedeoglu, Burcak Deniz, Akar, Halil, Kerman, Saim

Get full text

Results of reference pricing and reimbursement discount rate schemes of Turkey by Kockaya, Guvenc, Atikeler, Kagan, Tuna, Esin, Kılıc, Pelin, Tanyeri, Pelin, Umman, Nurcan, Vural, İsmail Mert, Altun, Omer, Akbulat, Akif, Artiran, Guven, Simsek, Ercan, Gursoz, Hakkı, Kerman, Saim

Get full text

Risk Management in Tianeptine Abuse in Turkey: A National Experience by Durmus, Nedim, Ozbilen, Gamze, Kasap, Yelda, Koyuncu, Oguzhan, Yildirim, Osman, Artiran, Guven, Kerman, Saim, Aydinkarahaliloglu, Demet

“…Objective: Tianeptine is used in the treatment of major depressive episodes and has structural similarities with tricyclic antidepressants although it has…”
Get full text

Risk Management in Tianeptine Abuse in Turkey: A National Experience/Türkiye'de tianeptinin kötüye kullanim risk yönetimi: Ulusal bir tecrübe by Durmus, Nedim, Ozbilen, Gamze, Kasap, Yelda, Koyuncu, Oguzhan, Yildirim, Osman, Artiran, Guven, Kerman, Saim, Aydinkarahaliloglu, Demet

Get full text

Evaluation of Neuropsychiatric Medicines Off-Label use Applications by Özdamar, Emine Nur, Gürsöz, Hakki, Alkan, Ali, Bayar, Banu, Kerman, Saim, Akici, Ahmet

Get full text